{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:32:37Z","timestamp":1778765557614,"version":"3.51.4"},"publisher-location":"Cham","reference-count":134,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031963636","type":"print"},{"value":"9783031963643","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-96364-3_5","type":"book-chapter","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:06:20Z","timestamp":1759737980000},"page":"121-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Causal Mechanisms of Monoamine Transporter Phosphorylation"],"prefix":"10.1007","author":[{"given":"Sammanda","family":"Ramamoorthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durairaj Ragu","family":"Varman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lankupalle D.","family":"Jayanthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1471-4159.2010.06898.x","volume":"115","author":"B Annamalai","year":"2010","unstructured":"Annamalai B, Mannangatti P, Arapulisamy O, Ramamoorthy S, Jayanthi LD (2010) Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis. J Neurochem 115:23\u201335","journal-title":"J Neurochem"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1124\/mol.111.073171","volume":"81","author":"B Annamalai","year":"2012","unstructured":"Annamalai B, Mannangatti P, Arapulisamy O, Shippenberg TS, Jayanthi LD, Ramamoorthy S (2012) Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function. Mol Pharmacol 81:73\u201385","journal-title":"Mol Pharmacol"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/acschemneuro.9b00664","volume":"11","author":"B Annamalai","year":"2020","unstructured":"Annamalai B, Ragu Varman D, Horton RE, Daws LC, Jayanthi LD, Ramamoorthy S (2020) Histamine receptors regulate the activity, surface expression, and phosphorylation of Serotonin transporters. ACS Chem Neurosci 11:466\u2013476","journal-title":"ACS Chem Neurosci"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"28599","DOI":"10.1074\/jbc.M113.472878","volume":"288","author":"O Arapulisamy","year":"2013","unstructured":"Arapulisamy O, Mannangatti P, Jayanthi LD (2013) Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization. J Biol Chem 288:28599\u201328610","journal-title":"J Biol Chem"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","volume":"74","author":"AH Ashok","year":"2017","unstructured":"Ashok AH, Mizuno Y, Volkow ND, Howes OD (2017) Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis. JAMA Psychiatry 74:511\u2013519","journal-title":"JAMA Psychiatry"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.taap.2004.08.013","volume":"204","author":"MJ Bannon","year":"2005","unstructured":"Bannon MJ (2005) The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol 204:355\u2013360","journal-title":"Toxicol Appl Pharmacol"},{"key":"5_CR7","first-page":"321","volume-title":"Psychopharmacology: the fourth generation of progress","author":"EL Barker","year":"1995","unstructured":"Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In: Psychopharmacology: the fourth generation of progress, pp 321\u2013333"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.53.4.649","volume":"53","author":"D Bengel","year":"1998","unstructured":"Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymetamphetamine (\u201cecstasy\u201d) in serotonin transporter-deficient mice. Mol Pharmacol 53:649\u2013655","journal-title":"Mol Pharmacol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1124\/pr.115.012260","volume":"68","author":"DP Bermingham","year":"2016","unstructured":"Bermingham DP, Blakely RD (2016) Kinase-dependent regulation of monoamine neurotransmitter transporters. Pharmacol Rev 68:888\u2013953","journal-title":"Pharmacol Rev"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"e0727232023","DOI":"10.1523\/JNEUROSCI.0727-23.2023","volume":"44","author":"DL Bernstein","year":"2024","unstructured":"Bernstein DL, Lewandowski SI, Besada C, Place D, Espana RA, Mortensen OV (2024) Inactivation of ERK1\/2 signaling in dopaminergic neurons by Map Kinase phosphatase MKP3 regulates dopamine signaling and motivation for cocaine. J Neurosci 44:e0727232023","journal-title":"J Neurosci"},{"issue":"1","key":"5_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","volume":"25","author":"M Bohm","year":"1995","unstructured":"Bohm M, La Rosse K, Schwinger RHG, Erdmann E (1995) Evidence for reduction norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25(1):146\u2013153","journal-title":"J Am Coll Cardiol"},{"key":"5_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.90","volume":"4","author":"E Bowton","year":"2014","unstructured":"Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry 4:e464","journal-title":"Transl Psychiatry"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/brainsci14090902","volume":"14","author":"N Boyle","year":"2024","unstructured":"Boyle N, Betts S, Lu H (2024) Monoaminergic modulation of learning and cognitive function in the prefrontal cortex. Brain Sci 14:902","journal-title":"Brain Sci"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1523\/JNEUROSCI.0894-20.2020","volume":"40","author":"ZD Brodnik","year":"2020","unstructured":"Brodnik ZD, Xu W, Batra A, Lewandowski SI, Ruiz CM, Mortensen OV, Kortagere S, Mahler SV, Espana RA (2020) Chemogenetic manipulation of Dopamine neurons dictates cocaine potency at distal dopamine transporters. J Neurosci 40:8767\u20138779","journal-title":"J Neurosci"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"ra117","DOI":"10.1126\/scisignal.aai8441","volume":"9","author":"TF Brust","year":"2016","unstructured":"Brust TF, Morgenweck J, Kim SA, Rose JH, Locke JL, Schmid CL, Zhou L, Stahl EL, Cameron MD, Scarry SM, Aube J, Jones SR, Martin TJ, Bohn LM (2016) Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci Signal 9:ra117","journal-title":"Sci Signal"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1038\/ncomms13877","volume":"8","author":"ES Calipari","year":"2017","unstructured":"Calipari ES, Juarez B, Morel C, Walker DM, Cahill ME, Ribeiro E, Roman-Ortiz C, Ramakrishnan C, Deisseroth K, Han MH, Nestler EJ (2017) Dopaminergic dynamics underlying sex-specific cocaine reward. Nat Commun 8:13877","journal-title":"Nat Commun"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.1074\/jbc.M117.787002","volume":"292","author":"S Challasivakanaka","year":"2017","unstructured":"Challasivakanaka S, Zhen J, Smith ME, Reith MEA, Foster JD, Vaughan RA (2017) Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding. J Biol Chem 292:19066\u201319075","journal-title":"J Biol Chem"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1038\/npp.2013.171","volume":"38","author":"VI Chefer","year":"2013","unstructured":"Chefer VI, Backman CM, Gigante ED, Shippenberg TS (2013) Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology 38:2623\u20132631","journal-title":"Neuropsychopharmacology"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/S0007125000291769","volume":"8","author":"EF Coccaro","year":"1989","unstructured":"Coccaro EF (1989) Central serotonin and impulsive aggression. Br J Psychiatry Suppl 8:52\u201362","journal-title":"Br J Psychiatry Suppl"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature17629","volume":"532","author":"JA Coleman","year":"2016","unstructured":"Coleman JA, Green EM, Gouaux E (2016) X-ray structures and mechanism of the human serotonin transporter. Nature 532:334\u2013339","journal-title":"Nature"},{"key":"5_CR21","first-page":"215","volume":"2","author":"P Compagnon","year":"1993","unstructured":"Compagnon P, Ernouf D, Narcisse G, Daoust M (1993) Serotonin in animal models of alcoholism. Alcohol Alcohol Suppl 2:215\u2013219","journal-title":"Alcohol Alcohol Suppl"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbr.2017.09.043","volume":"337","author":"GL Davis","year":"2018","unstructured":"Davis GL, Stewart A, Stanwood GD, Gowrishankar R, Hahn MK, Blakely RD (2018) Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Behav Brain Res 337:61\u201369","journal-title":"Behav Brain Res"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1471-4159.2010.06599.x","volume":"113","author":"J Eriksen","year":"2010","unstructured":"Eriksen J, Jorgensen TN, Gether U (2010) Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J Neurochem 113:27\u201341","journal-title":"J Neurochem"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.HYP.3.2.149","volume":"3","author":"M Esler","year":"1981","unstructured":"Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P (1981) Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 3:149\u2013156","journal-title":"Hypertension"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jchemneu.2016.10.004","volume":"83-84","author":"JD Foster","year":"2017","unstructured":"Foster JD, Vaughan RA (2017) Phosphorylation mechanisms in dopamine transporter regulation. J Chem Neuroanat 83-84:10\u201318","journal-title":"J Chem Neuroanat"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/3-540-29784-7_10","volume":"175","author":"JD Foster","year":"2006","unstructured":"Foster JD, Cervinski MA, Gorentla BK, Vaughan RA (2006) Regulation of the dopamine transporter by phosphorylation. Handb Exp Pharmacol 175:197\u2013214","journal-title":"Handb Exp Pharmacol"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","volume":"287","author":"JD Foster","year":"2012","unstructured":"Foster JD, Yang JW, Moritz AE, Challasivakanaka S, Smith MA, Holy M, Wilebski K, Sitte HH, Vaughan RA (2012) Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux. J Biol Chem 287:29702\u201329712","journal-title":"J Biol Chem"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.pharmtox.43.050802.112309","volume":"43","author":"RR Gainetdinov","year":"2003","unstructured":"Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261\u2013284","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1749-6632.2002.tb04515.x","volume":"971","author":"EM Garland","year":"2002","unstructured":"Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, Kim KS, Biaggioni I, Shannon JR, Blakely RD, Robertson D (2002) Genetic basis of clinical catecholamine disorders. Ann N Y Acad Sci 971:506\u2013514","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR30","first-page":"149","volume":"295","author":"B Giros","year":"1991","unstructured":"Giros B, Mestikawy SE, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. Feder Exp Biol Sci 295:149\u2013154","journal-title":"Feder Exp Biol Sci"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606\u2013612","journal-title":"Nature"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0026-895X(25)08925-4","volume":"42","author":"B Giros","year":"1992","unstructured":"Giros B, El Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383\u2013390","journal-title":"Mol Pharmacol"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/da.20642","volume":"27","author":"AW Goddard","year":"2010","unstructured":"Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27:339\u2013350","journal-title":"Depress Anxiety"},{"key":"5_CR34","volume-title":"Stress,catecholamines, and cardiovascular disease","author":"DS Goldstein","year":"1995","unstructured":"Goldstein DS (1995) Stress,catecholamines, and cardiovascular disease, 1st edn. Oxford University Press, New York","edition":"1"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2007.07.030","volume":"75","author":"A Goodman","year":"2008","unstructured":"Goodman A (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75:266\u2013322","journal-title":"Biochem Pharmacol"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/bi801696n","volume":"48","author":"BK Gorentla","year":"2009","unstructured":"Gorentla BK, Moritz AE, Foster JD, Vaughan RA (2009) Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48:1067\u20131076","journal-title":"Biochemistry"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1523\/JNEUROSCI.0055-18.2018","volume":"38","author":"R Gowrishankar","year":"2018","unstructured":"Gowrishankar R, Gresch PJ, Davis GL, Katamish RM, Riele JR, Stewart AM, Vaughan RA, Hahn MK, Blakely RD (2018) Region-specific regulation of presynaptic Dopamine homeostasis by D2 autoreceptors shapes the in vivo impact of the neuropsychiatric disease-associated DAT variant Val559. J Neurosci 38:5302\u20135312","journal-title":"J Neurosci"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.tpj.6500106","volume":"2","author":"MK Hahn","year":"2002","unstructured":"Hahn MK, Blakely RD (2002) Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2:217\u2013235","journal-title":"Pharmacogenomics J"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0306-4522(02)00379-2","volume":"115","author":"FS Hall","year":"2002","unstructured":"Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115:153\u2013161","journal-title":"Neuroscience"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1172\/JCI73778","volume":"124","author":"FH Hansen","year":"2014","unstructured":"Hansen FH et al (2014) Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest 124:3107\u20133120","journal-title":"J Clin Invest"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1155\/NP.2004.191","volume":"11","author":"CW Harley","year":"2004","unstructured":"Harley CW (2004) Norepinephrine and dopamine as learning signals. Neural Plast 11:191\u2013204","journal-title":"Neural Plast"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/0014-2999(95)00323-D","volume":"280","author":"DM Helmeste","year":"1995","unstructured":"Helmeste DM, Tang SW (1995) Tyrosine kinase inhibitors regulate serotonin uptake in platelets. Eur J Pharmacol 280:R5\u2013R7","journal-title":"Eur J Pharmacol"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","volume":"75","author":"LL Howell","year":"2008","unstructured":"Howell LL, Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196\u2013217","journal-title":"Biochem Pharmacol"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/01.RES.78.3.475","volume":"78","author":"M Imamura","year":"1996","unstructured":"Imamura M, Lander HM, Levi R (1996) Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors. Circ Res 78:475\u2013481","journal-title":"Circ Res"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1476-5381.1971.tb07066.x","volume":"41","author":"LL Iversen","year":"1971","unstructured":"Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571\u2013591","journal-title":"Br J Pharmacol"},{"key":"5_CR46","first-page":"381","volume-title":"Handbook of psychopharmacology","author":"LL Iversen","year":"1978","unstructured":"Iversen LL (1978) Uptake processes for biogenic amines. In: Iversen I (ed) Handbook of psychopharmacology, 3rd edn. Prenum Press, New York, pp 381\u2013442","edition":"3"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","volume":"72","author":"B Jacobs","year":"1992","unstructured":"Jacobs B, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165\u2013229","journal-title":"Physiol Rev"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"E728","DOI":"10.1208\/aapsj070373","volume":"7","author":"LD Jayanthi","year":"2005","unstructured":"Jayanthi LD, Ramamoorthy S (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7:E728\u2013E738","journal-title":"AAPS J"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"19315","DOI":"10.1074\/jbc.M311172200","volume":"279","author":"LD Jayanthi","year":"2004","unstructured":"Jayanthi LD, Samuvel DJ, Ramamoorthy S (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J Biol Chem 279:19315\u201319326","journal-title":"J Biol Chem"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1124\/mol.104.009555","volume":"67","author":"LD Jayanthi","year":"2005","unstructured":"Jayanthi LD, Samuvel DJ, Blakely RD, Ramamoorthy S (2005) Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol Pharmacol 67:2077\u20132087","journal-title":"Mol Pharmacol"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"23326","DOI":"10.1074\/jbc.M601156200","volume":"281","author":"LD Jayanthi","year":"2006","unstructured":"Jayanthi LD, Annamalai B, Samuvel DJ, Gether U, Ramamoorthy S (2006) Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J Biol Chem 281:23326\u201323340","journal-title":"J Biol Chem"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ph15101203","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zou D, Li Y, Gu S, Dong J, Ma X, Xu S, Wang F, Huang JH (2022) Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals (Basel) 15:1203","journal-title":"Pharmaceuticals (Basel)"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.neuroscience.2006.01.008","volume":"139","author":"NR Keller","year":"2006","unstructured":"Keller NR, Diedrich A, Appalsamy M, Miller LC, Caron MG, McDonald MP, Shelton RC, Blakely RD, Robertson D (2006) Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Neuroscience 139:931\u2013946","journal-title":"Neuroscience"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0968-0004(90)90073-K","volume":"15","author":"BE Kemp","year":"1990","unstructured":"Kemp BE, Pearson RB (1990) Protein kinase recognition sequence motifs. Trends Biochem Sci 15:342\u2013346","journal-title":"Trends Biochem Sci"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/mol.64.2.440","volume":"64","author":"F Kilic","year":"2003","unstructured":"Kilic F, Murphy DL, Rudnick G (2003) A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64:440\u2013446","journal-title":"Mol Pharmacol"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1196\/annals.1417.023","volume":"1129","author":"CH Kim","year":"2008","unstructured":"Kim CH, Waldman ID, Blakely RD, Kim KS (2008) Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Ann N Y Acad Sci 1129:256\u2013260","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuropharm.2014.07.016","volume":"86","author":"B Kivell","year":"2014","unstructured":"Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS (2014) Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1\/2-dependent mechanism. Neuropharmacology 86:228\u2013240","journal-title":"Neuropharmacology"},{"issue":"21","key":"5_CR58","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1523\/JNEUROSCI.17-21-08451.1997","volume":"17","author":"V Klimek","year":"1997","unstructured":"Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17(21):8451\u20138458","journal-title":"J Neurosci"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S1054-3589(08)60910-2","volume":"42","author":"GF Koob","year":"1998","unstructured":"Koob GF (1998) Circuits, drugs, and drug addiction. Adv Pharmacol 42:978\u2013982","journal-title":"Adv Pharmacol"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217\u2013238","journal-title":"Neuropsychopharmacology"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, Jorgensen TN, Sorensen L, Eriksen J, Loland CJ, Stromgaard K, Gether U (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585\u2013640","journal-title":"Pharmacol Rev"},{"key":"5_CR62","first-page":"1595","volume":"119","author":"MA Kurian","year":"2009","unstructured":"Kurian MA, Zhen J, Cheng SY, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, Pasha S, Wassmer E, Heales SJ, Gissen P, Reith ME, Maher ER (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest 119:1595\u20131603","journal-title":"J Clin Invest"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","volume":"10","author":"MA Kurian","year":"2011","unstructured":"Kurian MA et al (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10:54\u201362","journal-title":"Lancet Neurol"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0278-5846(88)90037-1","volume":"12","author":"SZ Langer","year":"1988","unstructured":"Langer SZ, Schoemaker H (1988) Effects of antidepressants on monoamine transporters. Prog Neuro-Psychopharmacol Biol Psychiat 12:193\u2013216","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiat"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/bjp.2008.131","volume":"154","author":"AJ Lawrence","year":"2008","unstructured":"Lawrence AJ, Beart PM, Kalivas PW (2008) Neuropharmacology of addiction--setting the scene. Br J Pharmacol 154:259\u2013260","journal-title":"Br J Pharmacol"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI114294","volume":"84","author":"C Liang","year":"1989","unstructured":"Liang C, Fan T-HM, Sullebarger JT, Sakamoto S (1989) Decreased adrenergic neuronal uptake activity in experimental right heart failure. J Clin Invest 84:1267\u20131275","journal-title":"J Clin Invest"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"20162","DOI":"10.1074\/jbc.M209584200","volume":"278","author":"Z Lin","year":"2003","unstructured":"Lin Z, Zhang PW, Zhu X, Melgari JM, Huff R, Spieldoch RL, Uhl GR (2003) Phosphatidylinositol 3-kinase, protein kinase C, and MEK1\/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites. J Biol Chem 278:20162\u201320170","journal-title":"J Biol Chem"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"20239","DOI":"10.1074\/jbc.M111.226811","volume":"286","author":"P Mannangatti","year":"2011","unstructured":"Mannangatti P, Arapulisamy O, Shippenberg TS, Ramamoorthy S, Jayanthi LD (2011) Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. J Biol Chem 286:20239\u201320250","journal-title":"J Biol Chem"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M114.612192","volume":"290","author":"P Mannangatti","year":"2015","unstructured":"Mannangatti P, NarasimhaNaidu K, Damaj MI, Ramamoorthy S, Jayanthi LD (2015) A role for p38 mitogen-activated protein kinase-mediated threonine 30-dependent Norepinephrine transporter regulation in cocaine sensitization and conditioned place preference. J Biol Chem 290:10814\u201310827","journal-title":"J Biol Chem"},{"key":"5_CR70","doi-asserted-by":"publisher","unstructured":"Mayer FP, Stewart A, Varman DR, Moritz AE, Foster JD, Owens AW, Areal LB, Gowrishankar R, Velez M, Wickham K, Phelps H, Katamish R, Rabil M, Jayanthi LD, Vaughan RA, Daws LC, Blakely RD, Ramamoorthy S (2025) Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03055-4","DOI":"10.1038\/s41380-025-03055-4"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.neuropharm.2005.08.012","volume":"49","author":"MS Mazei-Robison","year":"2005","unstructured":"Mazei-Robison MS, Blakely RD (2005) Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Neuropharmacology 49:737\u2013749","journal-title":"Neuropharmacology"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuropharm.2005.08.003","volume":"49","author":"MS Mazei-Robison","year":"2005","unstructured":"Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724\u2013736","journal-title":"Neuropharmacology"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","volume":"28","author":"MS Mazei-Robison","year":"2008","unstructured":"Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040\u20137046","journal-title":"J Neurosci"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD (2019) Schizophrenia, Dopamine and the Striatum: from biology to symptoms. Trends Neurosci 42:205\u2013220","journal-title":"Trends Neurosci"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11064-021-03299-w","volume":"47","author":"C Meinke","year":"2022","unstructured":"Meinke C, Quinlan MA, Paffenroth KC, Harrison FE, Fenollar-Ferrer C, Katamish RM, Stillman I, Ramamoorthy S, Blakely RD (2022) Serotonin transporter Ala276 Mouse: Novel Model to assess the neurochemical and behavioral impact of Thr276 phosphorylation in vivo. Neurochem Res 47:37\u201360","journal-title":"Neurochem Res"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"E4779","DOI":"10.1073\/pnas.1417294111","volume":"111","author":"MA Mergy","year":"2014","unstructured":"Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD (2014) The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proc Natl Acad Sci USA 111:E4779\u2013E4788","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00005344-199201000-00002","volume":"19","author":"P Merlet","year":"1992","unstructured":"Merlet P, Dubois-Rande J-L, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, Valette H, Castaigne A, Syrota A (1992) Myocardial b-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 19:10\u201316","journal-title":"J Cardiovasc Pharmacol"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"27351","DOI":"10.1016\/S0021-9258(18)46992-X","volume":"269","author":"KJ Miller","year":"1994","unstructured":"Miller KJ, Hoffman BJ (1994) Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 269:27351\u201327356","journal-title":"J Biol Chem"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mi.7.3.7","volume":"7","author":"M Miranda","year":"2007","unstructured":"Miranda M, Sorkin A (2007) Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms. Mol Interv 7:157\u2013167","journal-title":"Mol Interv"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.pnpbp.2005.08.007","volume":"29","author":"DA Morilak","year":"2005","unstructured":"Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO (2005) Role of brain norepinephrine in the behavioral response to stress. Prog Neuro-Psychopharmacol Biol Psychiatry 29:1214\u20131224","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1074\/jbc.M112.407874","volume":"288","author":"AE Moritz","year":"2013","unstructured":"Moritz AE, Foster JD, Gorentla BK, Mazei-Robison MS, Yang JW, Sitte HH, Blakely RD, Vaughan RA (2013) Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem 288:20\u201332","journal-title":"J Biol Chem"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/brain\/awu022","volume":"137","author":"J Ng","year":"2014","unstructured":"Ng J et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137:1107\u20131119","journal-title":"Brain"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrn3939","volume":"16","author":"DJ Nutt","year":"2015","unstructured":"Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR (2015) The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci 16:305\u2013312","journal-title":"Nat Rev Neurosci"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejphar.2014.10.031","volume":"753","author":"B Olivier","year":"2015","unstructured":"Olivier B (2015) Serotonin: a never-ending story. Eur J Pharmacol 753:2\u201318","journal-title":"Eur J Pharmacol"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","volume":"40","author":"MJ Owens","year":"1994","unstructured":"Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288\u2013295","journal-title":"Clin Chem"},{"issue":"895","key":"5_CR86","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.mp.4001365","volume":"8","author":"N Ozaki","year":"2003","unstructured":"Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL (2003) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8(895):933\u2013896","journal-title":"Mol Psychiatry"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/350350a0","volume":"350","author":"T Pacholczyk","year":"1991","unstructured":"Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350\u2013354","journal-title":"Nature"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000325216","volume":"27","author":"M Pavanetto","year":"2011","unstructured":"Pavanetto M, Zarpellon A, Borgo C, Donella-Deana A, Deana R (2011) Regulation of serotonin transport in human platelets by tyrosine kinase Syk. Cell Physiol Biochem 27:139\u2013148","journal-title":"Cell Physiol Biochem"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","volume":"19","author":"MT Perona","year":"2008","unstructured":"Perona MT, Waters S, Hall FS, Sora I, Lesch KP, Murphy DL, Caron M, Uhl GR (2008) Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 19:566\u2013574","journal-title":"Behav Pharmacol"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0014-2999(97)00100-3","volume":"325","author":"PD Prasad","year":"1997","unstructured":"Prasad PD, Torres-Zamorano V, Kekuda R, Leibach FH, Ganapathy V (1997) Functional link between tyrosine phosphorylation and human serotonin transporter gene expression. Eur J Pharmacol 325:85\u201392","journal-title":"Eur J Pharmacol"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/164_2021_499","volume":"271","author":"D Ragu Varman","year":"2021","unstructured":"Ragu Varman D, Jayanthi LD, Ramamoorthy S (2021a) Kappa Opioid Receptor mediated differential regulation of Serotonin and Dopamine transporters in mood and substance use disorder. Handb Exp Pharmacol 271:97","journal-title":"Handb Exp Pharmacol"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/jnc.15152","volume":"156","author":"D Ragu Varman","year":"2021","unstructured":"Ragu Varman D, Jayanthi LD, Ramamoorthy S (2021b) Glycogen synthase kinase-3ss supports serotonin transporter function and trafficking in a phosphorylation-dependent manner. J Neurochem 156:445\u2013464","journal-title":"J Neurochem"},{"key":"5_CR93","doi-asserted-by":"crossref","unstructured":"Ragu Varman D, Ramamoorthy S, Jayanthi LD (2025)Threonine-53 Phosphorylation of Dopamine Transporter Dictates kappa-Opioid Receptor-Mediated Locomotor Suppression, Aversion, and Cocaine Reward. J Neurosci 45:e0171252025","DOI":"10.1523\/JNEUROSCI.0171-25.2025"},{"key":"5_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113267","volume":"408","author":"D Ragu Varman","year":"2021","unstructured":"Ragu Varman D, Subler MA, Windle JJ, Jayanthi LD, Ramamoorthy S (2021c) Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter. Behav Brain Res 408:113267","journal-title":"Behav Brain Res"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s12031-022-01988-x","volume":"72","author":"D Ragu Varman","year":"2022","unstructured":"Ragu Varman D, Mannangatti P, Subler MA, Windle JJ, Ramamoorthy S, Jayanthi LD (2022) Blunted amphetamine-induced reinforcing behaviors and transporter downregulation in Knock-in mice carrying alanine mutations at Threonine-258 and Serine-259 of norepinephrine transporter. J Mol Neurosci 72:1965\u20131976","journal-title":"J Mol Neurosci"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/BJ20140826","volume":"468","author":"J Rajamanickam","year":"2015","unstructured":"Rajamanickam J, Annamalai B, Rahbek-Clemmensen T, Sundaramurthy S, Gether U, Jayanthi LD, Ramamoorthy S (2015) Akt-mediated regulation of antidepressant-sensitive serotonin transporter function, cell-surface expression and phosphorylation. Biochem J 468:177\u2013190","journal-title":"Biochem J"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1126\/science.285.5428.763","volume":"285","author":"S Ramamoorthy","year":"1999","unstructured":"Ramamoorthy S, Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763\u2013766","journal-title":"Science"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pharmthera.2010.09.009","volume":"129","author":"S Ramamoorthy","year":"2011","unstructured":"Ramamoorthy S, Shippenberg TS, Jayanthi LD (2011) Regulation of monoamine transporters: role of transporter phosphorylation. Pharmacol Ther 129:220\u2013238","journal-title":"Pharmacol Ther"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1074\/jbc.273.4.2458","volume":"273","author":"S Ramamoorthy","year":"1998","unstructured":"Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458\u20132466","journal-title":"J Biol Chem"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"11639","DOI":"10.1074\/jbc.M611353200","volume":"282","author":"S Ramamoorthy","year":"2007","unstructured":"Ramamoorthy S, Samuvel DJ, Buck ER, Rudnick G, Jayanthi LD (2007) Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J Biol Chem 282:11639\u201311647","journal-title":"J Biol Chem"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1073\/pnas.90.6.2542","volume":"90","author":"S Ramamoorthy","year":"1993","unstructured":"Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542\u20132546","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","volume":"1","author":"KJ Ressler","year":"2000","unstructured":"Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 1:2\u201319","journal-title":"Depress Anxiety"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1749-6632.2001.tb03703.x","volume":"940","author":"D Robertson","year":"2001","unstructured":"Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR, Jordan J, Jacob G, Blakely RD, Biaggioni I (2001) Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci 940:527\u2013543","journal-title":"Ann N Y Acad Sci"},{"key":"5_CR104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00424-013-1410-1","volume":"466","author":"G Rudnick","year":"2014","unstructured":"Rudnick G, Kramer R, Blakely RD, Murphy DL, Verrey F (2014) The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Pflugers Arch 466:25\u201342","journal-title":"Pflugers Arch"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1523\/JNEUROSCI.3754-04.2005","volume":"25","author":"DJ Samuvel","year":"2005","unstructured":"Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25:29\u201341","journal-title":"J Neurosci"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/01.RES.82.1.57","volume":"82","author":"M Schafers","year":"1998","unstructured":"Schafers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG (1998) Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertonic cardiomyopathy. Circ Res 82:57\u201362","journal-title":"Circ Res"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jnc.12686","volume":"129","author":"J Segura-Aguilar","year":"2014","unstructured":"Segura-Aguilar J, Paris I, Munoz P, Ferrari E, Zecca L, Zucca FA (2014) Protective and toxic roles of dopamine in Parkinson\u2019s disease. J Neurochem 129:898\u2013915","journal-title":"J Neurochem"},{"key":"5_CR108","first-page":"141","volume":"119","author":"EM Sellers","year":"1992","unstructured":"Sellers EM, Higgins GA, Tompkins DM, Romach MK (1992) Serotonin and alcohol drinking. NIDA Res Monogr 119:141\u2013145","journal-title":"NIDA Res Monogr"},{"key":"5_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphys.2023.100106","volume":"6","author":"M Shetty","year":"2023","unstructured":"Shetty M, Bolland DE, Morrell J, Grove BD, Foster JD, Vaughan RA (2023) Dopamine transporter membrane mobility is bidirectionally regulated by phosphorylation and palmitoylation. Curr Res Physiol 6:100106","journal-title":"Curr Res Physiol"},{"key":"5_CR110","first-page":"563","volume":"75","author":"TS Shippenberg","year":"1986","unstructured":"Shippenberg TS, Herz A (1986) Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res Monogr 75:563\u2013566","journal-title":"NIDA Res Monogr"},{"key":"5_CR111","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1073\/pnas.091039298","volume":"98","author":"I Sora","year":"2001","unstructured":"Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98:5300\u20135305","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR112","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0006-3223(99)00219-X","volume":"46","author":"SM Southwick","year":"1999","unstructured":"Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, Charney DS (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46:1192\u20131204","journal-title":"Biol Psychiatry"},{"key":"5_CR113","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1600-0854.2008.00757.x","volume":"9","author":"JA Steiner","year":"2008","unstructured":"Steiner JA, Carneiro AM, Blakely RD (2008) Going with the flow: trafficking-dependent and -independent regulation of serotonin transport. Traffic 9:1393\u20131402","journal-title":"Traffic"},{"key":"5_CR114","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/cells11244059","volume":"11","author":"A Stewart","year":"2022","unstructured":"Stewart A, Davis GL, Areal LB, Rabil MJ, Tran V, Mayer FP, Blakely RD (2022a) Male DAT Val559 mice exhibit compulsive behavior under devalued reward conditions accompanied by cellular and pharmacological changes. Cells 11:4059","journal-title":"Cells"},{"key":"5_CR115","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1038\/s41380-022-01773-7","volume":"27","author":"A Stewart","year":"2022","unstructured":"Stewart A, Mayer FP, Gowrishankar R, Davis GL, Areal LB, Gresch PJ, Katamish RM, Peart R, Stilley SE, Spiess K, Rabil MJ, Diljohn FA, Wiggins AE, Vaughan RA, Hahn MK, Blakely RD (2022b) Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters. Mol Psychiatry 27:4869\u20134880","journal-title":"Mol Psychiatry"},{"key":"5_CR116","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuropharm.2016.10.011","volume":"113","author":"S Sundaramurthy","year":"2017","unstructured":"Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S (2017) Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology 113:281\u2013292","journal-title":"Neuropharmacology"},{"key":"5_CR117","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/syn.10005","volume":"42","author":"AL Svingos","year":"2001","unstructured":"Svingos AL, Chavkin C, Colago EE, Pickel VM (2001) Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42:185\u2013192","journal-title":"Synapse"},{"key":"5_CR118","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249\u2013258","journal-title":"Eur J Pharmacol"},{"key":"5_CR119","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","volume":"20","author":"AC Thompson","year":"2000","unstructured":"Thompson AC, Zapata A, Justice JB Jr, Vaughan RA, Sharpe LG, Shippenberg TS (2000) Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 20:9333\u20139340","journal-title":"J Neurosci"},{"key":"5_CR120","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1155\/NP.2004.97","volume":"11","author":"D Viggiano","year":"2004","unstructured":"Viggiano D, Vallone D, Sadile A (2004a) Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. Neural Plast 11:97\u2013114","journal-title":"Neural Plast"},{"key":"5_CR121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1155\/NP.2004.133","volume":"11","author":"D Viggiano","year":"2004","unstructured":"Viggiano D, Ruocco LA, Arcieri S, Sadile AG (2004b) Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast 11:133\u2013149","journal-title":"Neural Plast"},{"key":"5_CR122","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1176\/appi.ajp.161.4.621","volume":"161","author":"N Volkow","year":"2004","unstructured":"Volkow N (2004) Drug dependence and addiction, III: expectation and brain function in drug abuse. Am J Psychiatry 161:621","journal-title":"Am J Psychiatry"},{"key":"5_CR123","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nrn1539","volume":"5","author":"ND Volkow","year":"2004","unstructured":"Volkow ND, Li TK (2004) Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 5:963\u2013970","journal-title":"Nat Rev Neurosci"},{"key":"5_CR124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1749-6632.1997.tb46188.x","volume":"820","author":"ND Volkow","year":"1997","unstructured":"Volkow ND, Wang GJ, Fowler JS (1997) Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann NY Acad Sci 820:41\u201355","journal-title":"Ann NY Acad Sci"},{"key":"5_CR125","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26:6583\u20136588","journal-title":"J Neurosci"},{"key":"5_CR126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/YPG.0b013e3282f08a06","volume":"18","author":"JR Wendland","year":"2008","unstructured":"Wendland JR, DeGuzman TB, McMahon F, Rudnick G, Detera-Wadleigh SD, Murphy DL (2008) SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder. Psychiatr Genet 18:31\u201339","journal-title":"Psychiatr Genet"},{"key":"5_CR127","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1124\/jpet.114.216820","volume":"352","author":"KL White","year":"2015","unstructured":"White KL, Robinson JE, Zhu H, DiBerto JF, Polepally PR, Zjawiony JK, Nichols DE, Malanga CJ, Roth BL (2015) The G protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo. J Pharmacol Exp Ther 352:98\u2013109","journal-title":"J Pharmacol Exp Ther"},{"key":"5_CR128","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/74839","volume":"3","author":"F Xu","year":"2000","unstructured":"Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465\u2013471","journal-title":"Nat Neurosci"},{"key":"5_CR129","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000113750","volume":"21","author":"A Zarpellon","year":"2008","unstructured":"Zarpellon A, Donella-Deana A, Folda A, Turetta L, Pavanetto M, Deana R (2008) Serotonin (5-HT) transport in human platelets is modulated by Src-catalysed Tyr-phosphorylation of the plasma membrane transporter SERT. Cell Physiol Biochem 21:87\u201394","journal-title":"Cell Physiol Biochem"},{"key":"5_CR130","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neuropharm.2005.06.019","volume":"49","author":"YW Zhang","year":"2005","unstructured":"Zhang YW, Rudnick G (2005a) Serotonin transporter mutations associated with obsessive-compulsive disorder and phosphorylation alter binding affinity for inhibitors. Neuropharmacology 49:791\u2013797","journal-title":"Neuropharmacology"},{"key":"5_CR131","doi-asserted-by":"publisher","first-page":"30807","DOI":"10.1074\/jbc.M504087200","volume":"280","author":"YW Zhang","year":"2005","unstructured":"Zhang YW, Rudnick G (2005b) Cysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformation. J Biol Chem 280:30807\u201330813","journal-title":"J Biol Chem"},{"key":"5_CR132","first-page":"E2776","volume":"113","author":"YW Zhang","year":"2016","unstructured":"Zhang YW, Turk BE, Rudnick G (2016) Control of serotonin transporter phosphorylation by conformational state. Proc Natl Acad Sci USA 113:E2776\u2013E2783","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR133","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1523\/JNEUROSCI.0034-07.2007","volume":"27","author":"YW Zhang","year":"2007","unstructured":"Zhang YW, Gesmonde J, Ramamoorthy S, Rudnick G (2007) Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by a mutation associated with obsessive compulsive disorder. J Neurosci 27:10878\u201310886","journal-title":"J Neurosci"},{"key":"5_CR134","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1124\/mol.65.6.1462","volume":"65","author":"CB Zhu","year":"2004","unstructured":"Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD (2004) Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65:1462\u20131474","journal-title":"Mol Pharmacol"}],"container-title":["Advances in Neurobiology","Monoamine Transporters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-96364-3_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:04:10Z","timestamp":1776798250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-96364-3_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031963636","9783031963643"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-96364-3_5","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"7 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}